| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | Norway | 3 | |
| #3 | United States | 3 | |
| #4 | China | 2 | |
| #5 | Canada | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Singh Jasbir | 13 |
| #2 | Gurney Mark | 10 |
| #3 | Hategan Georgeta | 6 |
| #4 | Yu Peng | 5 |
| #5 | Sandanayaka Vincent | 4 |
| #6 | Zembower David | 3 |
| #7 | Zhao Lei | 3 |
| #8 | Zhou Nian | 3 |
| #9 | Gurney Mark E | 3 |
| #10 | Polozov Alexandre | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2569763A1 | 2,4-diaminoquinazolines for spinal muscular atrophy | |
| WO2005112637A1 | Formulations for non-parenteral use including hydrophobic cyclodextrins |